57 posts | 1 images
Pharmaceutical Management Agency of New Zealand is part of the New Zealand medicines system and work to improve people's access to medicine, and to promote their optimal use.
PHARMAC is welcoming the appointment of Dr Sisira Jayathissa to the chairmanship of PTAC, says Medical Director Dr Peter Moodie.
664 views
Funded treatment options for New Zealand’s most common form of cancer will take a step forward in August when PHARMAC begins funding gefitinib (Iressa), a targeted treatment for lung cancer.
1,387 views
PHARMAC will extend funding to a type of antibiotic that can be used to treat and prevent pertussis (whooping cough) in children under one.
1,022 views
PHARMAC’s consultation on the proposal to change to a sole supplier of blood glucose testing strips and meters has ended with over 3000 submissions received.
746 views
With less than a week remaining, PHARMAC is keen to hear the public’s views on its proposal to fund insulin pumps.
687 views
PHARMAC is funding two new targeted cancer medicines following an agreement with GlaxoSmithKline.
721 views
A surge in the medicines budget over the past three years, combined with PHARMAC’s savings programmes, has seen PHARMAC investing heavily in new medicines.
718 views
NAPIER — The IronMāori event in Napier on 3 December is serious competition but brings a serious health message too, says PHARMAC’s Māori health manager Marama Parore.
1,226 views
Papers released by PHARMAC today outline the careful consideration given before funding was approved for the new-generation anticoagulant drug dabigatran (Pradaxa).
718 views
Getting closer to district health boards, on whose behalf PHARMAC aims to spend $777 million this year, took on a new meaning today.
705 views
Cancer treatment has taken another step forward with PHARMAC recently approving wider funding for two cancer treatments.
677 views
PHARMAC is moving to a more permissive and streamlined system for assessing people seeking medicines that aren’t funded on the Pharmaceutical Schedule.
710 views
PHARMAC is funding two new treatments for the bone-thinning disease osteoporosis.
676 views
A New Zealand preventative health campaign which has significantly improved take-up of cholesterol lowering medication among Maori and Pacific Island males sets the bar for Australia to develop its own initiatives to achieve similar outcomes for Indigenous Australians.
1,038 views
PHARMAC is welcoming the reappointment of Waikato Hospital physician Dr Graham Mills to the Pharmacology and Therapeutics Advisory Committee (PTAC).
708 views
PHARMAC is funding an innovative form of anti-blood clotting treatment that will significantly change the way anticoagulation is managed in New Zealand.
739 views
Kiwis could be paying more for pharmaceuticals if the Trans Pacific Partnership (TPP) free trade negotiations are successful, the Green Party said today.
610 views
PHARMAC is enabling New Zealanders with multiple myeloma (MM) to benefit from early use of a new treatment, bortezomib (Velcade) as well as providing wider access to thalidomide, another treatment used for MM.
782 views
People with epilepsy will have a new funded treatment from 1 May, when PHARMAC begins funding for lacosamide (Vimpat).
698 views
PHARMAC will fund a new treatment for the sleep disorder narcolepsy from 1 May 2011.
715 views
Changes in access rules for funded special foods will see more prescribers able to supply funded special foods to patients.
721 views
PHARMAC is welcoming the appointment of three new members to the Pharmacology and Therapeutics Advisory Committee (PTAC).
887 views
Learning from past experience will serve PHARMAC well as it takes a greater role in purchasing hospital medicines, says Chief Executive Matthew Brougham.
731 views
Government drug funder PHARMAC will provide wider access to treatments for multiple sclerosis (MS), and fund new blood-thinning and antibiotic treatments following an agreement with Bayer New Zealand Limited.
721 views
PHARMAC is adding two further treatments for depression to the Pharmaceutical Schedule from 1 December 2010.
697 views
People with brain tumours are to have greater access to an expensive cancer drug from 1 December.
698 views
Patients with a form of kidney cancer will have a new treatment option as part of a multi-product agreement between PHARMAC and Pfizer.
779 views
A $40 million lift in pharmaceutical spending has led to a significant rise in the number of medicines available to New Zealanders, and the number of people receiving them.
717 views
PHARMAC has launched a new online tool that will give people a look inside PHARMAC’s evaluation of medicine funding applications.
870 views
Two newly funded medicines will help the fight against drug-resistant strains of the human immunodeficiency virus (HIV) in a multi-product deal that will also help fight infections in hospitals.
796 views
Decisions by PHARMAC will see easier access to treatments for people at risk of heart attack or stroke because of raised cholesterol levels.
558 views
PHARMAC and the Asthma Foundation have today launched a new website designed to help people better manage children’s asthma.
645 views
Funding a new drug for people with advanced lung cancer and widening access to two other cancer treatments are features of a new agreement PHARMAC has reached with pharmaceutical company Roche Products (NZ) Ltd.
711 views
Price reductions for antipsychotic medicines will release $24 million of savings over the next five years which PHARMAC can use to fund other medicines, the Government drug funder says.
584 views
The heart drug clopidogrel is to have open access from next month, following a major price reduction negotiated by PHARMAC.
524 views
The PHARMAC Board has appointed five new members to the Government drug funder’s Consumer Advisory Committee.
646 views
People with both Type 1 and Type 2 diabetes are set to benefit from recent decisions by Government drug funder PHARMAC.
352 views
PHARMAC has confirmed people with Alzheimer’s disease and other forms of dementia will have funded access to donepezil from 1 November.
569 views
Women wanting longer-term contraception will have a new funded option from 1 August, following a decision by Government medicine funder PHARMAC.
551 views
Consistent national access to medicines for patients and more effective use of DHB funding will be the aims of PHARMAC’s involvement in funding hospital medicines and medical devices, Chief Executive Matthew Brougham says.
319 views
PHARMAC will fund a further pain relief treatment option – tramadol 50mg capsules - from 1 June.
703 views
People with Alzheimer’s Disease and other forms of dementia will have access to a funded medicine for the first time, following a decision by PHARMAC.
360 views
Promoting competition through its purchasing strategies is continuing to provide long-term benefits, according to Government medicine funder PHARMAC.
594 views
PHARMAC is seeking a medical opinion – it wants doctors’ advice on how it can best communicate with clinicians.
456 views
Prescriptions for government funded medicines increased by almost 4 percent last year to 36.3 million, but the rate of that growth is slowing, drug buying agency PHARMAC says.
627 views
An antidepressant that will be funded from 1 November will help meet an unmet need for people with severe depression, says PHARMAC’s medical director Dr Peter Moodie.
763 views
PHARMAC is acknowledging the role health professionals played in implementing medicine brand changes that affected a very large number of New Zealanders during 2008/09.
506 views
Government medicine funder PHARMAC is asking for feedback on options for improving its consumer participation.
493 views
New funded treatments for HIV/AIDS and nausea, and a strengthened osteoporosis treatment have emerged from an agreement between PHARMAC and pharmaceutical company Merck Sharp & Dohme (MSD).
566 views
PHARMAC has completed agreements with two companies for the heart drug metoprolol that will realise $65 million of savings over the next five years.
445 views
PHARMAC is funding a new medication for patients with chronic myeloid leukaemia, called dasatinib (Sprycel).
559 views
People with a number of painful and disabling inflammatory conditions will avoid hospital visits for treatment following a funding decision by PHARMAC.
760 views
Government drug funder PHARMAC is welcoming the increase in the pharmaceutical budget, which it says will help ensure people continue to have improving access to medicines.
472 views
PHARMAC is investing in a new medication to help overcome drug resistance for people with hepatitis B.
1,132 views
Savings on three pharmaceuticals achieved by PHARMAC will free up $27 million for spending on new medicines over the next three years.
500 views
Funding azithromycin for cystic fibrosis is great news for patients and will save the health sector money, says Government drug-funder PHARMAC.
456 views
PHARMAC is seeking feedback on a proposal to fund a new brand of oil in water emulsion cream (healthE Fatty Cream) on the Pharmaceutical Schedule.
1,262 views